Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma | NEJM

Original Article from The New England Journal of Medicine — Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma

Read the full article here

Related Articles